FR2081547B1 - - Google Patents

Info

Publication number
FR2081547B1
FR2081547B1 FR7106704A FR7106704A FR2081547B1 FR 2081547 B1 FR2081547 B1 FR 2081547B1 FR 7106704 A FR7106704 A FR 7106704A FR 7106704 A FR7106704 A FR 7106704A FR 2081547 B1 FR2081547 B1 FR 2081547B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7106704A
Other versions
FR2081547A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of FR2081547A1 publication Critical patent/FR2081547A1/fr
Application granted granted Critical
Publication of FR2081547B1 publication Critical patent/FR2081547B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
FR7106704A 1970-02-27 1971-02-26 Expired FR2081547B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2009343A DE2009343C3 (de) 1970-02-27 1970-02-27 Verwendung von Lysolecithinen als immunologische Adjuvantien

Publications (2)

Publication Number Publication Date
FR2081547A1 FR2081547A1 (fr) 1971-12-03
FR2081547B1 true FR2081547B1 (fr) 1974-03-22

Family

ID=5763599

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7106704A Expired FR2081547B1 (fr) 1970-02-27 1971-02-26

Country Status (7)

Country Link
US (1) US3752886A (fr)
BE (1) BE763580A (fr)
DE (1) DE2009343C3 (fr)
FR (1) FR2081547B1 (fr)
GB (1) GB1334138A (fr)
NL (1) NL7102368A (fr)
ZA (1) ZA711242B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1502774A (en) * 1974-06-25 1978-03-01 Nat Res Dev Immunological preparations
DE2619686C2 (de) * 1976-05-04 1986-08-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verwendung eines Lysolecithins zur Tumorbehandlung
GB2046092B (en) * 1979-03-05 1983-11-02 Toyama Chemical Co Ltd Pharmaceutical composition containing a lysophospholid and a phospholipid
US4439199A (en) * 1980-02-19 1984-03-27 Alza Corporation Method for administering immunopotentiator
US4455142A (en) * 1980-07-07 1984-06-19 Alza Corporation Method of coadministering an antigen and an immunopotentiator
US4484923A (en) * 1982-03-25 1984-11-27 Alza Corporation Method for administering immunopotentiator
US4666893A (en) * 1983-02-15 1987-05-19 St. Thomas Institute Methods of inducing resistance to bacterial and viral infections
JPS6045518A (ja) * 1983-08-22 1985-03-12 Takeda Chem Ind Ltd 抗シヨツク剤
US4923854A (en) * 1986-01-22 1990-05-08 The Liposome Company, Inc. Solubilization of hydrophobic materials using lysophospholipid
US5084269A (en) * 1986-11-06 1992-01-28 Kullenberg Fred W Adjuvant for dose treatment with antigens
DE3918082A1 (de) * 1989-06-02 1991-01-24 Max Planck Gesellschaft Mittel gegen autoimmunerkrankungen
IE912535A1 (en) * 1990-07-27 1992-01-29 Res Dev Foundation Liposomes that Provide Thymic Dependent Help to Weak Vaccine¹Antigens
CA2092731A1 (fr) * 1993-03-26 1994-09-27 Yaping Shen Utilisation de dimycolates de trehalose a amide et de dimycolates de trehalose a thioesther symetriques par rapport au plan pour le diagnostic de la tuberculose
PT785773E (pt) * 1994-10-14 2001-05-31 Liposome Co Inc Lipossomas de eteres lipidicos e sua utilizacao terapeutica
US5942246A (en) * 1996-02-16 1999-08-24 The Liposome Company, Inc. Etherlipid containing multiple lipid liposomes
US6667053B1 (en) 1996-02-16 2003-12-23 Elan Pharmaceuticals, Inc. D and L etherlipid stereoisomers and liposomes
US6007839A (en) * 1996-02-16 1999-12-28 The Liposome Company, Inc. Preparation of pharmaceutical compositions containing etherlipid-containing multiple lipid liposomes
USRE39042E1 (en) * 1996-02-16 2006-03-28 The Liposome Company, Inc. Etherlipid-containing multiple lipid liposomes
US5965159A (en) 1996-02-16 1999-10-12 The Liposome Company, Inc. Etherlipid-containing multiple lipid liposomes
US5932242A (en) * 1996-10-15 1999-08-03 The Liposome Company, Inc. Ether lipid-containing pharmaceutical compositions and therapeutic uses thereof

Also Published As

Publication number Publication date
NL7102368A (fr) 1971-08-31
DE2009343C3 (de) 1980-10-23
BE763580A (fr) 1971-08-26
FR2081547A1 (fr) 1971-12-03
GB1334138A (en) 1973-10-17
ZA711242B (en) 1971-12-29
DE2009343A1 (de) 1971-09-02
US3752886A (en) 1973-08-14
DE2009343B2 (de) 1980-02-28

Similar Documents

Publication Publication Date Title
AR204384A1 (fr)
ATA96471A (fr)
AU1146470A (fr)
AU2044470A (fr)
AU2017870A (fr)
AU2130570A (fr)
AU2085370A (fr)
AR195465A1 (fr)
AU1004470A (fr)
ATA672271A (fr)
AU1083170A (fr)
AU1064870A (fr)
AU2144270A (fr)
AU1189670A (fr)
AU1235770A (fr)
AU1247570A (fr)
AU2061170A (fr)
AU1086670A (fr)
AU2112570A (fr)
AU2115870A (fr)
AU2119370A (fr)
AU1277070A (fr)
AU2130770A (fr)
AU2131570A (fr)
AU1343870A (fr)

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse